Results 221 to 230 of about 2,242,026 (306)

Effect of autonomous motivation support on obesity prevention in early adolescents: a study protocol of cluster-randomized controlled trial based on the integrated SDT-TPB framework. [PDF]

Trials
Kong JQ, Chen J, Yang Y, Yang YH, Liu JY, Hu RZ, Li JY, Zhang XR, Liu Z.   +8 more
europepmc   +1 more source

Cotton‐Swab‐Anchored Suspension Technique for Hands‐Free Lower Extremity Limb Sterilization During Surgical Preparation

Arthroscopy Techniques, EarlyView.
Abstract Manual limb suspension during surgical preparation is labor‐intensive, requires additional personnel, and may increase the risk of musculoskeletal injuries among surgical staff. We describe a cotton‐swab‐anchored suspension technique that uses a sterile bandage (Kerlix) looped around the ankle, secured with 2 cotton swabs inserted into the ...
Chen Zhou, Zhouzhou Hu, Lather Sagar, Shengwu Yang, Zhenhan Deng   +4 more
wiley   +1 more source

Randomized Controlled Trial Outcomes for HomeStyles-2, an Online Obesity Prevention Program for Families with Children in Middle Childhood. [PDF]

Nutrients
Byrd-Bredbenner C, Pozzoli AA, Eck KM, Worobey J, Shelnutt KP, Olfert MD, Quick V.   +6 more
europepmc   +1 more source

Long‐Term Risk of Rheumatoid Arthritis in Individuals With Autism Spectrum Disorder: A Population‐Based Matched Cohort Study

Autism Research, EarlyView.
ABSTRACT To investigate the long‐term risk of rheumatoid arthritis (RA) among individuals with autism spectrum disorder (ASD), addressing potential immune comorbidity in ASD populations. A population‐based matched cohort was assembled using Swedish registers, including 46,164 individuals diagnosed with ASD between 1987 and 2017, matched to 4,634,895 ...
Evora Hailin Zhu, Stephen Z. Levine, Matilda Morin, Weiyao Yin, Benjamin Christofferson, Johan Askling, Natalia Rivera, Abraham Reichenberg, Joseph D. Buxbaum, Sven Sandin, Benjamin Hon Kei Yip   +10 more
wiley   +1 more source

Obesity Prevention and Reduction in China Using the Social Media Platform WeChat: Scoping Review. [PDF]

Interact J Med Res
Wang Y, Zhuang X, Sundermeir S, Gittelsohn J.   +3 more
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Recommender systems for obesity prevention: Scoping review of reviews. [PDF]

SAGE Open Med
De Santis KK, Stiens L, Christianson L, Forberger S.   +3 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Barriers and Facilitators to Increased Parental, Caregiver, and Community Engagement in Obesity Prevention Targeting Vulnerable Children: A Qualitative Study in Greece. [PDF]

Healthcare (Basel)
Balafouti T, Svolos V, Argyropoulou M, Roussos R, Strongylou DE, Mavrogianni C, Halilagic A, Koukouli S, Moschonis G, Manios Y, Androutsos O, Mouratidou T.   +11 more
europepmc   +1 more source

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad, Anshu Arora, Arun Arora, Jeena Vaid, Arif Khan   +4 more
wiley   +1 more source